Abbvie products

April 17, 2023. U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine. QULIPTA® now the first and only oral CGRP receptor antagonist approved to …
Trends
AbbVie eye care scientists are focused on challenging eye diseases with innovative medicines to preserve and protect vision. Learn about their research interests, disease …
NORTH CHICAGO, Ill., and WALTHAM, Mass., Nov. 30, 2023 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) and ImmunoGen, Inc. (NASDAQ: IMGN) …
AbbVie is a biopharmaceutical company that focuses on neuroscience research and development for neurological and psychiatric disorders. Learn about their …
Home. Healthcare Professionals, Get The Answers You Are Searching For Here. Search for information or submit an inquiry to the AbbVie Medical Information team. Begin your …
  • Safe
  • Encrypted

AbbVie offers a range of products for patients with various conditions, such as cancer, diabetes, fibromyalgia, and more. Learn how AbbVie products can help patients …
  • Safe
  • Encrypted

Allergan Aesthetics offers a range of products and technologies for facial and body aesthetics, such as BOTOX®, JUVÉDERM®, CoolSculpting®, and more. Learn about …
  • Safe
  • Encrypted

Our product portfolio of biologics and specialty focused medicines addresses needs in disease areas including immunology, oncology, virology and neuroscience.
  • Safe
  • Encrypted

NORTH CHICAGO, Ill. , May 12, 2022 / PRNewswire / -- AbbVie (NYSE: ABBV) will present 46 abstracts across eight types of cancer during the upcoming American Society …
e-AbbVie: Pharmaceutical Product Catalog. By Product number. Enter the 11- digit NDC/GTIN Number specific for the product you are searching. By Alphabet. Click on the …
  • Safe
  • Encrypted

See more